Clinical trial
Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
NCT00003745 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003745 |
|---|---|
| Title | Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas |
| Official title | A Phase II Study of Continuous 21 Day Infusion of Topotecan (NSC # 609699) in Children With Relapsed Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride |
| Enrollment | 125 |
| Start date | May 1, 1999 |
| Primary completion | Jun 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 5, 2013 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: